Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Immunophenotypic Lineage Assessment By Multiparameter Flow Cytometry Provides More Precise MDS Prognosis

Ikenna Onyekwere, BS, Julie Perilla Garcia, BS, MS, Kamal Menghrajani, MD, Alexander Chan, MD, Christopher Famulare, MS, Minal A Patel, MPH, John Philip, BA, MS, Martin S. Tallman, MD, Virginia M. Klimek, MD, Ross L. Levine, MD, Wenbin Xiao, MD PhD, Jacob L Glass, MDPhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-143154

Published: 2020

Journal Articles

Venetoclax Therapy for Relapsed and Treatment Refractory AML: Clinical Outcomes and Molecular Predictors

Maximilian Stahl, MD, Kamal Menghrajani, MD, Andriy Derkach, PhD, Alexander Chan, MD, Wenbin Xiao, MD PhD, Jacob L Glass, MDPhD, Amber C. King, PharmD, BCOP, Anthony Daniyan, MD, Christopher Famulare, MS, Bernadette M. Cuello, BSN, MSN, NP, RN, Omar Abdel-Wahab, MD, Ross L. Levine, MD, Aaron D Viny, MDMS, Eytan M. Stein, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD, Aaron D Goldberg, MDPhD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-137815

Published: 2020

Journal Articles

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-137749

Published: 2020

Journal Articles

LSD1 Inhibitor CPI-482 Shows Efficacy and Prolongs Survival in Mouse Models of AML and Post-MPN AML in the Context of Constitutive JAK-STAT Pathway Activation

Raajit K. Rampal, MD PhD, John P. McGrath, PhD, Aishwarya Krishnan, BS, Bing Li, MD, Wenbin Xiao, MD PhD, David Nikom, Jing Wang, PhD, Ross L. Levine, MD, Patrick Trojer, PhD

Blood (2020) 136 (Supplement 1): 50–51.

https://doi.org/10.1182/blood-2020-140186

Published: 2020

Journal Articles

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Blood (2019) 134 (Supplement_1): 2148.

https://doi.org/10.1182/blood-2019-125068

Published: 2019

Journal Articles

PRMT5 Inhibition Modulates E2F1 Methylation and Gene Regulatory Networks Leading to Therapeutic Efficacy in JAK2VF Mutant MPN

Blood (2019) 134 (Supplement_1): 473.

https://doi.org/10.1182/blood-2019-127122

Published: 2019

Journal Articles

Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological Control

Blood (2019) 134 (Supplement_1): 279.

https://doi.org/10.1182/blood-2019-123464

Published: 2019

Journal Articles

Aberrant SYK Expression As a Potential Therapeutic Target in T/NK Cell Neoplasms

Jing-Ping Zhang, PhD, Qi Gao, MLS, Alexander Chan, MD, Wenbin Xiao, MD PhD, Sary El Daker, PhD, Mikhail Roshal, MD PhD, Ahmet Dogan, MD PhD

Blood (2019) 134 (Supplement_1): 3978.

https://doi.org/10.1182/blood-2019-130406

Published: 2019

Journal Articles

Plasmacytoid Dendritic Cell Proportion Is Predictive of Risk and Outcomes in Myelodysplastic Syndromes

Alexander Chan, MD, Yanming Zhang, MD, Sean M. Devlin, PhD, Natasha Lewis, MD, Jeeyeon Baik, Maria E Arcila, MD, Virginia M. Klimek, MD, Mikhail Roshal, MD PhD, Wenbin Xiao, MD PhD

Blood (2019) 134 (Supplement_1): 5439.

https://doi.org/10.1182/blood-2019-122332

Published: 2019

Journal Articles

Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia

Mindy P Kresch, BS, Wenbin Xiao, MD PhD, Kamal Menghrajani, MD, Christopher Famulare, MS, Minal A Patel, MPH, Jeeyeon Baik, Mikhail Roshal, MD PhD, Ross L. Levine, MD, Martin S. Tallman, MD, Jacob L Glass, MD PhD

Blood (2019) 134 (Supplement_1): 2718.

https://doi.org/10.1182/blood-2019-131104

Published: 2019

Journal Articles

Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation: Predominantly Secondary AML, Enriched for RUNX1 Mutations, Frequent Cross-Lineage Antigen Expression and Poor Prognosis

Wenbin Xiao, MD, Aaron D Goldberg, MD PhD, Christopher Famulare, MS, Jeeyeon Baik, Qi Gao, Martin S. Tallman, MD, Yanming Zhang, MD, Maria E Arcila, MD, Mikhail Roshal, MD PhD

Blood (2018) 132 (Supplement 1): 2789.

https://doi.org/10.1182/blood-2018-99-119081

Published: 2018

Journal Articles

PHF6 Mutations Are Mutually Exclusive to TP53 Mutations, and Define a Distinct Subgroup of Secondary Acute Myeloid Leukemia Associated with a Primitive Stem/Progenitor Immunophenotype, Absent Complex Karyotype and Relatively Better Outcomes

Wenbin Xiao, MD, Aaron D Goldberg, MD PhD, Brian Ball, Christopher Famulare, MS, Friederike Pastore, MD, Martin S. Tallman, MD, Yanming Zhang, MD, Maria E Arcila, MD, Elli Papaemmanuil, PhD, Ross L. Levine, MD, Mikhail Roshal, MD PhD

Blood (2018) 132 (Supplement 1): 2788.

https://doi.org/10.1182/blood-2018-99-118985

Published: 2018

Journal Articles

Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 1523.

https://doi.org/10.1182/blood-2018-99-112591

Published: 2018

Journal Articles

PHF6 Mutations Defines a Subgroup of Mixed Phenotype of Acute Leukemia with Aberrant T-Cell Differentiation

Wenbin Xiao, MD, Friederike Pastore, MD, Bartlomiej Getta, MD, Anne Hultquist, MD, Brian C. Shaffer, MD, Sergio A. Giralt, MD, Raajit K. Rampal, MD PhD, Maria E. Arcila, Ross L. Levine, MD, Mikhail Roshal, MDPhD

Blood (2017) 130 (Supplement 1): 1384.

https://doi.org/10.1182/blood.V130.Suppl_1.1384.1384

Published: 2017

Journal Articles

Development Of Mature T Lymphocytes Requires Alpha-Synuclein

Afshin Shameli, MD, PhD, Wenbin Xiao, MD, PhD, Clifford Harding, MD, PhD, Howard Meyerson, MD, John Sumodi, BSc, AAS, Robert Maitta, MD, PhD

Blood (2013) 122 (21): 3490.

https://doi.org/10.1182/blood.V122.21.3490.3490

Published: 2013

Journal Articles

B Cell Development Is Regulated By a-Synuclein, a Key Player In Parkinson’s Disease

Wenbin Xiao, MD, PhD, Afshin Shameli, MD, PhD, Clifford Harding, MD, PhD, Howard Meyerson, MD, Robert Maitta, MD, PhD

Blood (2013) 122 (21): 785.

https://doi.org/10.1182/blood.V122.21.785.785

Published: 2013

Journal Articles

Stratification Of CLL By ZAP-70 Expression: Analysis Of Samples From The ECOG-Led Intergroup Trial E2997

David Kaplan, MD/PhD, Zhuoxin Sun, PhD, Martin S. Tallman, MD, Ian W. Flinn, MD, PhD, Wenbin Xiao, MD, PhD, Paolo F. Caimi, MD, Nicholas M. Kaye, PhD, Hillard M. Lazarus, MD

Blood (2013) 122 (21): 4116.

https://doi.org/10.1182/blood.V122.21.4116.4116

Published: 2013

NARROW

Immunophenotypic Lineage Assessment By Multiparameter Flow Cytometry Provides More Precise MDS Prognosis

Venetoclax Therapy for Relapsed and Treatment Refractory AML: Clinical Outcomes and Molecular Predictors

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

LSD1 Inhibitor CPI-482 Shows Efficacy and Prolongs Survival in Mouse Models of AML and Post-MPN AML in the Context of Constitutive JAK-STAT Pathway Activation

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

PRMT5 Inhibition Modulates E2F1 Methylation and Gene Regulatory Networks Leading to Therapeutic Efficacy in JAK2VF Mutant MPN

Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological Control

Aberrant SYK Expression As a Potential Therapeutic Target in T/NK Cell Neoplasms

Plasmacytoid Dendritic Cell Proportion Is Predictive of Risk and Outcomes in Myelodysplastic Syndromes

Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia

Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation: Predominantly Secondary AML, Enriched for RUNX1 Mutations, Frequent Cross-Lineage Antigen Expression and Poor Prognosis

PHF6 Mutations Are Mutually Exclusive to TP53 Mutations, and Define a Distinct Subgroup of Secondary Acute Myeloid Leukemia Associated with a Primitive Stem/Progenitor Immunophenotype, Absent Complex Karyotype and Relatively Better Outcomes

Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia

PHF6 Mutations Defines a Subgroup of Mixed Phenotype of Acute Leukemia with Aberrant T-Cell Differentiation

Development Of Mature T Lymphocytes Requires Alpha-Synuclein

B Cell Development Is Regulated By a-Synuclein, a Key Player In Parkinson’s Disease

Stratification Of CLL By ZAP-70 Expression: Analysis Of Samples From The ECOG-Led Intergroup Trial E2997

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only